| Level I | Good quality evidence |
Systematic review of RCTs with consistent findings High quality individual RCT |
| Level II |
Limited quality patient orientated evidence |
Systematic review of lower quality studies or studies with inconsistent findings Low quality clinical trial Cohort studies Case-control studies |
| Level III | Other |
Consensus guidelines, extrapolations from bench research, usual practice, opinion, disease-oriented evidence (intermediate or physiologic outcomes only), or case series |
[6] Mifepristone (Medical TOP): Royal College of Obstetrics and Gynaecology Guidelines.The Care of Women Requesting Induced Abortion (Evidence-based Clinical Guideline No. 7), 2011. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/the-care-of-women-requesting-induced-abortion/
Mifepristone (Medical TOP): WHO.Safe abortion: technical and policy guidance for health systems, 2014. http://www.who.int/reproductivehealth/publications/unsafe_abortion/en/
Mifepristone (Medical TOP): National Department of Health, Essential Drugs Programme: Adult Hospital Level STGs and EML, 2019. http://www.health.gov.za/
Mifepristone (Medical TOP): Republic of South Africa.Choice on Termination of Pregnancy Act Amendment 1 of 2008. http://www.gov.za/documents/choice-termination-pregnancy-amendment-act
Mifepristone (Medical TOP): National Department of Health: Affordable Medicines, EDP- Primary Health Care. Medicine Review: Can TOPs be accomplished safely and effectively without ultrasound, July 2016. http://www.health.gov.za/